Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer
This study has been completed.
National Cancer Centre, Singapore
Information provided by (Responsible Party):
Wan-Teck Darren Lim, National Cancer Centre, Singapore
First received: June 19, 2008
Last updated: October 17, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2012|
|Primary Completion Date:||April 2012 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Sutiman N, Zhang Z, Tan EH, Ang MK, Tan SW, Toh CK, Ng QS, Chowbay B, Lim WT. Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules. PLoS One. 2016 May 2;11(5):e0154316. doi: 10.1371/journal.pone.0154316. eCollection 2016.